Grant RDF
pages:- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- more...
- A Phase 2B/3, Multi-Center, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Safety . . .
- A Phase 3 Double-Blind Multi-Center Randomized Placebo- Controlled Trial With Azt
- A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Treatment Nave and Treatment Experienced Subjects....
- A Phase 3 Multi Center Randomized Double Blind Placebo Controlled Parallel Group Study to Compare Efficacy and Safety
- A Phase 3 Multi-Center, Randomized, Double-Blind, Placebo- Controlled Study of the Effects of Once-Daily Oral Doses . .
- A Phase 3 Multicenter Randomized Open Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Gs-5885 Fixed-Dose Combination ± Ribavirin for 12 and 24 Weeks in Treatment-Experienced Subjects with Chronic Genotype 1 HCV Infection
- A Phase 3 Multicenter Randomized Placebo Controlled Double Blind Study to Evaluate the Safety and Efficarcy of .........
- A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects with Moderately to Severely Active Ulcerative Colitis
- A Phase 3 Open-Label,Prospective,Multicenter Study of the Pharmacokinetics,Efficacy,Safety, and Tolerability of Immune..
- A Phase 3 Prospective, Rndnzd, Dbl-Bld, Plcbo-Contld, Multi-Center, Tolerance and Efficacy Study of Rsd1235 in Subjects
- A Phase 3 Prospective, Uncontrolled, Multicenter Study Evaluating Pharmacokinetics,Efficacy,Safety.....
- A Phase 3 Randomised, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of S-888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Elective Invasive Procedures (L-PLUS 2)
- A Phase 3 Randomized Double Blind Placebo Controlled Study Investigating the Efficacy and Safety of Cvt-301 ...........
- A Phase 3 Randomized Multi-Center Open-Label Study to Evaluate the Efficacy and Safety of Leuprolide Acetate 11.25
- A Phase 3 Randomized Placebo-Controlled Double-Blind Multi-Ccenter Study to Evaluate the Safety and Efficacy......
- A Phase 3 Randomized Study of the Efficacy & Safety of Posaconazole Versus Voriconazole for the Treatment..........
- A Phase 3 Randomized, Open-Label Study Evaluating Dn-101 in Combination With Docetaxel in Androgen-Independent Prostate
- A Phase 3 Study of 2 Dose Regimens of Telaprevir in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin......
- A Phase 3 Study with Asunaprevir and Daclatasvir (DUAL) for Null or Partial Responders to Peg interferon Alfa and Ribavirin (P/R), Intolerant or Ineligible to P/R Subjects and Treatment-Naïve Subjects with Chronic Hepatitis C Genotype 1b Infection
- A Phase 3 Switchover Study of the Efficacy and Safety of Bmn 01 (Gilt-Tagged Recombinant Human Gaa) in Rhgaa. . .
- A Phase 3 Trial to Evaluate the Safety and Efficacy of Triple Therapy With Saxagliptin and to Dapagliflozin ......
- A Phase 3, 12-Week, Double-Blind, Placebo-Controlled, Ramdomized Multicentered Study to Evaluate the Efficancy of Oral..
- A Phase 3, 40 Week, Active-Controlled, Double-Blind Extension Study of Preladenant in Subjects With Moderate to
- A Phase 3, Db/Bd Multicenter, Randomized, Placebo-Controlledtrial Evaluating Repeated Courses of Aztreonam for Inhalatio
- A Phase 3, Double-Blind Extension Study Evaluating the Efficacy and Safety of Two Different Dose Levels......
- A Phase 3, Double-Blind, Double-Dummy, Multi-Center, Prospective, Randomized Study of the Efficacy and Safety . .
- A Phase 3, Double-Blind, Multicenter, Multinational, Randomized, Placebo-Controlled Trial Evaluating Aztreonam Lysinate
- A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Evaluate the Safety and Efficacy . . .
- A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Evaluate the Safety and Efficacy of
- A Phase 3, Double-Blind, Randomized, Multisite Trail of the Efficacy, Safety, and Tolerability of the Fixed Combination.